We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mechanical Stress Modifies Growth of Tumor Cultures and Response to Chemotherapeutic Agents

By LabMedica International staff writers
Posted on 18 Aug 2015
Print article
Image: Electron micrograph showing bone cancer cells populating the surface of a bioscaffold that had been placed in a flow perfusion bioreactor to evaluate the cells' response to the mechanical forces they experience in the body (Photo courtesy of the University of Texas MD Anderson Cancer Center and Rice University).
Image: Electron micrograph showing bone cancer cells populating the surface of a bioscaffold that had been placed in a flow perfusion bioreactor to evaluate the cells' response to the mechanical forces they experience in the body (Photo courtesy of the University of Texas MD Anderson Cancer Center and Rice University).
A more effective method of assessing the response of tumors to chemotherapeutic drugs utilizes three-dimensional culture growth combined with the application of mechanical stress factors that the tumor would experience in vivo.

Investigators at Rice University (Houston, TX, USA) and the University of Texas MD Anderson Cancer Center (Houston, USA) developed a method for culturing Ewing sarcoma (ES) cells on three-dimensional scaffolds within a flow perfusion bioreactor, which provided mechanical stimulation by changing the fluid viscosity and flow rate to induce flow-derived shear stress.

Results published in the August 3, 2015, edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) revealed that in the 10 day study, the steady flow of fluid through the scaffold prompted the sarcoma cells to proliferate throughout the structure. Shear stress induced the cells to significantly increase their production of IGF-1 protein and also down-regulated the production of two other cancer-related proteins, c-KIT and HER2, compared with tumors grown in static two-dimensional cultures.

This finding was particularly relevant, given the central role of the IGF-1/IGF-1 receptor (IGF-1R) pathway in ES tumorigenesis and as a promising clinical target. The insulin-like growth factors (IGFs) are proteins with high sequence similarity to insulin. IGFs are part of a complex system that cells use to communicate with their physiologic environment. This complex system consists of two cell-surface receptors (IGF-IR and IGF-IIR), two ligands (IGF-I and IGF-II), a family of six high-affinity IGF-binding proteins (IGFBP 1-6), as well as associated IGFBP degrading enzymes.

The use of a tissue-engineered model for this study, rather than human tumors or xenografts, enabled precise control of the forces experienced by the ES cells. This controlled environment enabled the observation that flow perfusion enhanced, in a rate-dependent manner, the sensitivity of ES cells to dalotuzumab, a drug that disrupts the IGF-1 pathway. The conditions used in this study allowed the investigators to demonstrate the shear stress-dependent ES cell sensitivity to dalotuzumab, highlighting the importance of biomechanical stimulation on ES-acquired drug resistance to IGF-1R inhibition.

"Mechanical forces are present in our bodies even though we are not always aware of them," said first author Dr. Marco Santoro, a graduate researcher in chemical and biomolecular engineering at The University of Texas MD Anderson Cancer Center. "Our cells are sensitive to the forces around them and change their behavior accordingly. Tumor cells behave the same way, changing their function depending on the forces they sense. For the first time, we showed how the effect of the drug changes according to the forces experienced by the cells. IGF-1 is crucial for this kind of sarcoma, which relies on this mechanism for growth. We show that the higher the mechanical stimulation, the more pronounced the secretion of this particular protein."

Related Links:

Rice University
University of Texas MD Anderson Cancer Center


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.